Med. praxi. 2018;15(4):197-202 | DOI: 10.36290/med.2018.065
Care of a patient after PCI at the general practitioner’s surgery
- II. interní klinika kardiologie a angiologie VFN a 1. LF UK, Praha
A patient after PCI, whether performed in association with ACS or not, will always remain a patient with IHD who is supposedto follow all the principles of secondary prevention. These include lifestyle and pharmacological measures. Ideally, the care isprovided by a cardiologist in collaboration with the general practitioner whose role is irreplaceable. Particular attention has tobe paid to the immediate postoperative period.
Keywords: percutaneous coronary intervention, acute coronary syndrome, secondary IHD prevention
Received: February 1, 2019; Accepted: March 26, 2019; Prepublished online: March 26, 2019; Published: September 1, 2018 Show citation
References
- Neoficiální statistika ČKS za rok 2017 zpracovaná podle hlášení všech katetrizačních laboratoří v ČR.
- Špinar J, et al. Summary of the 2016 ESC Guidelines on the diagnosis and treatment of acute and chronic heart failure. Prepared by the Czech Society of Cardiology. Cor et Vasa 2016; 58: e530-e568. Dostupné na www: http://www.sciencedirect.com/science/article/pii/S0010865016300996.
Go to original source... - Zdravotnická ročenka České republiky 2016. ÚZIS Praha 2017 [online]. Dostupné na www: https://www.uzis.cz/publikace/zdravotnicka-rocenka-ceske-republiky-2016.
- Želízko M, et al. Summary of the 2013 ESC guidelines on the management of stable coronary artery disease. Prepared by the Czech Society of Cardiology. Cor et Vasa 2014; 56: e259-e273. Dostupné na www: http://www.sciencedirect.com/science/article/pii/S001086501400023X. Go to original source...
- Kala P, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: Summary of the document prepared by the Czech Society of Cardiology. Cor et Vasa 2017; 59: e613-e644. Dostupné na www: na https://www.sciencedirect.com/science/article/pii/S0010865017301674. Go to original source...
- Jolly SS, Amlani S, Hamon M, Yusuf S, Mehta SR. Radial versus femoral access for coronary angiography or intervention and the impact on major bleeding and ischemic events: a systematic review and meta-analysis of randomized trials. Am Heart J 2009; 157: 132-140. Go to original source...
Go to PubMed... - Moťovská Z, et al. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS. Summary of the document prepared by the Czech Society of Cardiology. Cor et Vasa 2017; 59: e592-e612. Dostupné na www: https://www.sciencedirect.com/science/article/pii/S0010865017301728. Go to original source...
- Bultas J, Karetová D. Enterosolventní forma kyseliny acetylsalicylové - ano, či ne? Remedia 2017; 2: 145-151.
- Wallentin L, Becker RC, Budaj A, et al. PLATO Investigators. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 2009; 361: 1045-1057. Go to original source... Go to PubMed...
- Montalescot G, Wiviott SD, Braunwald E, et al. TRITON-TIMI 38 Investigators. Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial. Lancet 2009; 373: 723-731. Go to original source... Go to PubMed...
- Costa F, van Klaveren D, James S, el al. Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials. Lancet 2017; 389: 1025-1034. Go to original source... Go to PubMed...
- Janský P, et al. 2016 ESC/EAS Guidelines for the management of dyslipidaemias: Summary of the document prepared by the Czech Society of Cardiology. Cor et Vasa 2017; 59: e389-e415. Dostupné na www: http://www.sciencedirect.com/science/article/pii/S0010865017300371. Go to original source...
- Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344: 1383-1389. Go to original source...
- Dagenais GR, Pogue J, Fox K, Simoons ML, Yusuf S. Angiotensin-converting-enzyme inhibitors in stable vascular disease without left ventricular systolic dysfunction or heart failure: a combined analysis of three trials. Lancet 2006; 368: 581-588. Go to original source... Go to PubMed...
- Short PM, Lipworth SI, Elder DH, Schembri S, Lipworth BJ. Effect of beta blockers in treatment of chronic obstructive pulmonary disease: a retrospective cohort study. BMJ 2011; 342: d2549. Go to original source... Go to PubMed...
- Piepolli FM, et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice. European Heart Journal 2016; 37: 2315-2381. Go to original source... Go to PubMed...